Sayantani
Chatterjee, PhD (Australia) is currently a posdoctoral research fellow in the Analytical
Glycoimmunology Group from Macquarie University in Sydney.
Her research
encompasses cancer glycoimmunology. Previously, she was a postdoctoral
associate at Boston University and her research focused on investigating viral
glycoproteomics, particularly of Influenza and SARS-CoV-2, using ion mobility
mass spectrometry. She is originally from India where she received her BSc in
Microbiology (Honours) (2015) from St. Xavier’s College (Autonomous) and moved
to Australia to pursue Master of Research (2017) and subsequently PhD (2021) in
the Analytical Glycoimmunology Group focusing on mannose-terminating
glycoproteins involved in human health and disease.
She has been a HUPO ECR
member since 2022 and was also the Vice-Chair Logistics (2-year term) for the
22nd and 23rd HUPO World Congresses.